V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques.
Saved in:
| Title: | V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques. |
|---|---|
| Authors: | Styles TM; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Gangadhara S; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Reddy PBJ; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Sahoo A; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Shiferaw A; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Welbourn S; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States., Kozlowski PA; Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States., Derdeyn CA; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Pathology and Laboratory Medicine, Emory School of Medicine, Emory University, Atlanta, GA, United States., Velu V; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Pathology and Laboratory Medicine, Emory School of Medicine, Emory University, Atlanta, GA, United States., Amara RR; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Jul 22; Vol. 13, pp. 914969. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35935987 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Styles+TM%22">Styles TM</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Gangadhara+S%22">Gangadhara S</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Reddy+PBJ%22">Reddy PBJ</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Sahoo+A%22">Sahoo A</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Shiferaw+A%22">Shiferaw A</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Welbourn+S%22">Welbourn S</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Kozlowski+PA%22">Kozlowski PA</searchLink>; Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.<br /><searchLink fieldCode="AU" term="%22Derdeyn+CA%22">Derdeyn CA</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Pathology and Laboratory Medicine, Emory School of Medicine, Emory University, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Velu+V%22">Velu V</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Pathology and Laboratory Medicine, Emory School of Medicine, Emory University, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Amara+RR%22">Amara RR</searchLink>; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Jul 22; Vol. 13, pp. 914969. <i>Date of Electronic Publication: </i>2022 Jul 22 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35935987 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.914969 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 914969 Titles: – TitleFull: V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Styles TM – PersonEntity: Name: NameFull: Gangadhara S – PersonEntity: Name: NameFull: Reddy PBJ – PersonEntity: Name: NameFull: Sahoo A – PersonEntity: Name: NameFull: Shiferaw A – PersonEntity: Name: NameFull: Welbourn S – PersonEntity: Name: NameFull: Kozlowski PA – PersonEntity: Name: NameFull: Derdeyn CA – PersonEntity: Name: NameFull: Velu V – PersonEntity: Name: NameFull: Amara RR IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 07 Text: 2022 Jul 22 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
